EDGAR Filing Documents for 0001564590-18-017916

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001564590-18-017916

Filing Date

2018-07-30

Accepted

2018-07-30 17:25:51

Documents

Effectiveness Date

2018-07-30

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	kalv-s8.htm	S-8	96176
2	EX-5.1	kalv-ex51_6.htm	EX-5.1	14675
3	EX-23.1	kalv-ex231_40.htm	EX-23.1	2474
4	EX-23.2	kalv-ex232_41.htm	EX-23.2	2129
5	GRAPHIC	gjxn13wxss5a000001.jpg	GRAPHIC	37811
	Complete submission text file	0001564590-18-017916.txt		169025

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)